We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
What kind of difference can one year make? Just ask some Teva analysts, who these days seem upbeat that the Israeli drugmaker's cost-cutting measures are paying off.